Their Mission
Disrupting Health Industry
They are modernizing a $200 billion personal health research and management industry.  They bring new technology to a space lacking innovation for decades.  In a few years, they have made a far-reaching impact, and they continue to race ahead at light speed.

The future of developing new cures is headed towards personalized treatment.  Today, they are on the cusp of medical and scientific breakthroughs never before possible – ushered in by multi-omics, phenotyping, bioinformatics, and computational capacity. Like never before, the convergence of multiple fields of science and technology are coming together to develop new treatments.  They’re seeing rapid translational pathways from scientific research to consumer deployments at a scale and speed never before possible.

Vignet is powering this next generation of precision medicine where wearables sensors, data science, machine learning, artificial intelligence (AI), and analytics pave the way for actionable insights that reimagine health in new ways.

Vignet partners with the health ecosystem to accelerate discoveries based on real-world evidence and scientific rigor. Committed to collaboration and shared findings, they enable device manufacturers and pharmaceutical companies to bring products to market, and empower advocacy groups, care providers, payers, researchers, businesses, and consumers to connect and innovate.

Vignet has pioneered an adaptive platform for personalized engagement Vignet Research Platform (VRP) that combines the power of data through disparate sources such as genomics, environmental exposures, family history, electronic health records, biomarkers, and lifestyle management to derive insights and scientific discoveries.

The VRP is delivered through Vignet Research Platform SaaS model to enable large-scale digital therapeutics deployments with speed and efficiency.